Missing/wrong data?
Log in to edit
Phase 1 study of the selective BTK inhibitor zanubrutinib in B-cell malignancies and safety and efficacy evaluation in CLL
scientific article published on 24 July 2019
Author/s
author: Constantine S. Tam, Judith Trotman, Jan A Burger, John F Seymour, David Simpson, Andrew W. Roberts
Work details
Publication date
July 24, 2019
-
-
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.